SlateStone Wealth’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Buy |
14,092
+869
| +7% | +$224K | 0.34% | 76 |
|
|
2025
Q1 | $2.96M | Buy |
13,223
+977
| +8% | +$219K | 0.3% | 83 |
|
|
2024
Q4 | $2.8M | Buy |
12,246
+696
| +6% | +$159K | 0.27% | 86 |
|
|
2024
Q3 | $2.82M | Buy |
11,550
+1,152
| +11% | +$281K | 0.25% | 88 |
|
|
2024
Q2 | $1.99M | Buy |
10,398
+1,112
| +12% | +$213K | 0.22% | 96 |
|
|
2024
Q1 | $1.84M | Buy |
9,286
+1,108
| +14% | +$219K | 0.18% | 102 |
|
|
2023
Q4 | $1.41M | Sell |
8,178
-910
| -10% | -$157K | 0.18% | 103 |
|
|
2023
Q3 | $1.34M | Buy |
9,088
+876
| +11% | +$130K | 0.2% | 101 |
|
|
2023
Q2 | $1.79M | Buy |
8,212
+118
| +1% | +$25.8K | 0.34% | 65 |
|
|
2023
Q1 | $1.77M | Buy |
8,094
+1,559
| +24% | +$342K | 0.37% | 61 |
|
|
2022
Q4 | $1.36M | Buy |
6,535
+1,101
| +20% | +$229K | 0.33% | 71 |
|
|
2022
Q3 | $1.19M | Buy |
+5,434
| New | +$1.19M | 0.32% | 69 |
|